Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Junichi Mineno
Phase I Clinical Trial of Adoptive Transfer of Expanded Natural Killer Cells in Combination With IgG1 Antibody in Patients With Gastric or Colorectal Cancer
International Journal of Cancer
Cancer Research
Oncology
CD19 Target-Engineered T-Cells Accumulate at Tumor Lesions in Human B-Cell Lymphoma Xenograft Mouse Models
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Related publications
Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Phase I Trial of Sorafenib in Combination With Gefitinib in Patients With Refractory or Recurrent Non Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
Adoptive Transfer Studies Demonstrating the Antiviral Effect of Natural Killer Cells in Vivo
Journal of Experimental Medicine
Medicine
Allergy
Immunology
A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer
Investigational New Drugs
Oncology
Pharmacology
Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
Phase I/Ii Studies of Combination Chemotherapy With S-1 and Platinum in Patients With Previously Untreated Metastatic or Recurrent Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Phase I Study of TAS-102 and Irinotecan Combination Therapy in Japanese Patients With Advanced Colorectal Cancer
Investigational New Drugs
Oncology
Pharmacology
Systemic Interleukin-2 and Adoptive Transfer of Lymphokine-Activated Killer Cells Improves Antibody-Dependent Cellular Cytotoxicity in Patients With Relapsed B-Cell Lymphoma Treated With Rituximab
Clinical Cancer Research
Cancer Research
Oncology
